Bio-Path Holdings Inc Stock Nasdaq
Equities
US09057N1028
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.12M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.14
x | P/E ratio 2025 * |
-0.14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Bio-Path Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 07-05-09 | |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
Douglas Morris
FOU | Founder | 69 | 07-05-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Morris
FOU | Founder | 69 | 07-05-09 |
Heath Cleaver
BRD | Director/Board Member | 51 | 14-02-10 |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.70% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
+27.16% | 12.05B | |
-3.63% | 11.7B | |
+7.30% | 11.1B |